Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center

Hackensack, New Jersey 07601

2 studies enrolling now · 4 studies all time

What they study most

BRAF V600 Mutation, Ependymoma, Glioblastoma, High Grade Glioma, IDH1 Gene Mutation, IDH2 Gene Mutation, Low Grade Glioma, Low Grade Glioma of Brain, Low-grade Glioma, Malignant Glioma, Recurrent Glioblastoma, Recurrent Low Grade Glioma

Studies at this site

• Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas — Recruiting now
• Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) — Recruiting now
• BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas — Running, not enrolling
• HUMC 1612: Optune NovoTTF-200A System — Completed